Evidence map›Paper›PMID 40045087›Full record

ArticleTranslational stroke research2025

Stroke Mechanisms in Intracranial Atherosclerotic Disease: A Modified Classification System and Clinical Implications.

Shuang Li, Xuan Tian, Xueyan Feng, Bonaventure Ip, Hing Lung Ip, Jill Abrigo, Lina Zheng, Yuying Liu, Yu Liu, Ziqi Li and 13 more

Abstract read
In one paragraph

Article in Translational stroke research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Shuang LiDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Xuan TianDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Xueyan FengDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Bonaventure IpDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Hing Lung IpDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Jill AbrigoDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Lina ZhengDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Yuying LiuDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Yu LiuDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Ziqi LiDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Tingjun LiangDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Karen K Y MaDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Florence S Y FanDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Sze Ho MaDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Hui FangDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bo SongDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuming XuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Howan LeungDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Yannie O Y SooDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Vincent C T MokDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Ka Sing WongDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China.
Xinyi LengDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China. xinyi_leng@cuhk.edu.hk.
Thomas W H LeungDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, Shatin, China. drtleung@cuhk.edu.hk.

Funding

Early Career Scheme 24103122
6 · The paper itself

Abstract

backgroundIn patients with symptomatic intracranial atherosclerotic stenosis (sICAS), recent evidence has suggested an association between artery-to-artery embolism (AAE) and cortical borderzone (CBZ) infarcts.

methodsWe recruited patients with 50-99% anterior-circulation sICAS in this cohort. Stroke mechanisms were categorized as isolated parent artery atherosclerosis occluding penetrating artery (PAO), isolated AAE, isolated hypoperfusion, and mixed mechanisms, using two classification systems. In Classification I, the probable stroke mechanisms of internal borderzone and CBZ infarcts were both hypoperfusion, which were respectively hypoperfusion and AAE in Classification II. Other classification criteria were the same. We investigated and compared the predictive values of the two systems in predicting 90-day and 1-year recurrent ischemic stroke in the same territory (SIT).

resultsAmong 145 patients (median age 62 years), 101 (69.7%) were males. We found significant difference in the proportions of baseline stroke mechanisms between these two systems (p < 0.001). Eleven (7.6%) and 19 (13.1%) patients respectively had 90-day or 1-year recurrent SIT. Classification II better predicted the risk of 90-day recurrent SIT than Classification I, when patients were divided into 4 groups according to baseline stroke mechanisms (p = 0.029), or by the presence of hypoperfusion (p < 0.001). The two classification systems had comparable predictive values for 1-year recurrent SIT.

conclusionsIn medically treated sICAS patients, considering AAE rather than hypoperfusion as the stroke mechanism for CBZ infarcts could better predict early recurrent SITs.

Indexed as

Intracranial ArteriosclerosisIschemic StrokeStrokeAgedCohort StudiesFemaleHumansMaleMiddle AgedDiffusion-weighted imagingIntracranial atherosclerotic stenosisIschemic strokeStroke mechanismsStroke recurrence

Identifiers

PMID40045087
PMCPMC12391173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.